Sight Sciences Inc (NAS:SGHT)

Q4 2025 Sight Sciences Inc Earnings Call Transcript

Mar 4, 2026 / 09:30 PM GMT

Release Date Price: $5.41 (+2.85%)

Transcript 10-K8-K

Key Points

Positve

Sight Sciences Inc (SGHT) reported a 7% increase in total revenue for the fourth quarter of 2025, reaching $20.4 million.
Interventional glaucoma revenue grew by 5% year over year, driven by increases in ordering accounts and average selling prices.
Interventional dry eye revenue increased from $0.3 million to $0.7 million, reflecting positive traction in the reimbursed business model.
The company achieved a gross margin of 87%, consistent with the prior year, with interventional glaucoma gross margin at 88% and interventional dry eye gross margin improving to 68%.
Sight Sciences Inc (SGHT) reduced total operating expenses by 25% compared to the prior year, reflecting lower personnel-related expenses and stock-based compensation.

Negative

The company ended the quarter with $92 million in cash and cash equivalents, down from $120.4 million at the end of 2024.
Cash usage was $0.4 million in the quarter, indicating continued operational discipline but also reflecting a decrease in cash reserves.
The first quarter of 2026 is expected to be the lowest revenue quarter for the interventional glaucoma segment, with growth projected in low single digits.
The company faces challenges in expanding market access for its interventional dry eye segment, with only two MACs currently providing reimbursement.
Sight Sciences Inc (SGHT) anticipates an increase in adjusted operating expenses by 6 to 9% in 2026, driven by targeted market access and commercial investments.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

SGHT.OQ - Sight Sciences Inc
Q4 2025 Sight Sciences Inc Earnings Call
Mar 04, 2026 / 09:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good day everyone and welcome to Psych Science's 4th quarter 2025 earnings results. At this time, all participants are in a listen-only mode. After the presentation, there will be a question-and-answer session. To participate, you will need to press 11 on your telephone. You will then hear a message advising your hand is raised. To withdraw your question, simply press 11 again. Please note this conference is being recorded. Now it's my pleasure to turn the call over to Trip Taylor with Investor relations. Please proceed.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you for

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.